MARIO HERRERA: Open Payments
NPI 1326728874 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 54 payments from 11 companies in 2025. Trend: 2023 $884 · 2024 $3,662 · 2025 $2,075
Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $402 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $389 |
| Neurocrine BioSciences, Inc. | 14 | $382 |
| E.R. Squibb & Sons, L.L.C. | 6 | $314 |
| Janssen Pharmaceuticals, Inc | 4 | $187 |
| Axsome Therapeutics, Inc. | 4 | $177 |
| ABBVIE INC. | 1 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Teleflex LLC | 2 | $45 |
| Lundbeck LLC | 2 | $33 |
Products named: CAPLYTA, COBENFY, INGREZZA, AUSTEDO XR, Auvelity, UZEDY, INVEGA SUSTENNA, VRAYLAR.
Industry payments across NM — which companies pay providers there.
